Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB
· Real-Time Price · USD
6.16
-0.16 (-2.53%)
At close: Oct 16, 2025, 3:59 PM
5.90
-4.22%
After-hours: Oct 16, 2025, 06:51 PM EDT
-2.53% (1D)
| Bid | 5.93 |
| Market Cap | 479.67M |
| Revenue (ttm) | 3.12M |
| Net Income (ttm) | -154.08M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -2.21 |
| Forward PE | -3.24 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.43 |
| Volume | 862,662 |
| Avg. Volume (20D) | 1,199,614 |
| Open | 6.38 |
| Previous Close | 6.32 |
| Day's Range | 5.99 - 6.53 |
| 52-Week Range | 2.41 - 7.37 |
| Beta | 2.54 |
| Ex-Dividend Date | n/a |
About SLDB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLDB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLDB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+10.6%
Solid Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
+8.51%
Solid Biosciences shares are trading higher after the company announced it received FDA Fast Track Designation status for SGT-501 gene therapy.
